NM_000719.7:c.4254G>A
Variant names:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_000719.7(CACNA1C):c.4254G>A(p.Trp1418*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 33)
Consequence
CACNA1C
NM_000719.7 stop_gained
NM_000719.7 stop_gained
Scores
5
1
1
Clinical Significance
Conservation
PhyloP100: 10.0
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603.6 | c.4254G>A | p.Trp1418* | stop_gained | Exon 35 of 47 | 5 | NM_001167623.2 | ENSP00000382512.1 | ||
CACNA1C | ENST00000399655.6 | c.4254G>A | p.Trp1418* | stop_gained | Exon 35 of 47 | 1 | NM_000719.7 | ENSP00000382563.1 | ||
CACNA1C | ENST00000682544.1 | c.4488G>A | p.Trp1496* | stop_gained | Exon 37 of 50 | ENSP00000507184.1 | ||||
CACNA1C | ENST00000406454.8 | c.4254G>A | p.Trp1418* | stop_gained | Exon 35 of 48 | 5 | ENSP00000385896.3 | |||
CACNA1C | ENST00000399634.6 | c.4221G>A | p.Trp1407* | stop_gained | Exon 34 of 47 | 5 | ENSP00000382542.2 | |||
CACNA1C | ENST00000683824.1 | c.4419G>A | p.Trp1473* | stop_gained | Exon 36 of 48 | ENSP00000507867.1 | ||||
CACNA1C | ENST00000347598.9 | c.4398G>A | p.Trp1466* | stop_gained | Exon 37 of 49 | 1 | ENSP00000266376.6 | |||
CACNA1C | ENST00000344100.7 | c.4320G>A | p.Trp1440* | stop_gained | Exon 35 of 47 | 1 | ENSP00000341092.3 | |||
CACNA1C | ENST00000327702.12 | c.4254G>A | p.Trp1418* | stop_gained | Exon 35 of 48 | 1 | ENSP00000329877.7 | |||
CACNA1C | ENST00000399617.6 | c.4254G>A | p.Trp1418* | stop_gained | Exon 35 of 48 | 5 | ENSP00000382526.1 | |||
CACNA1C | ENST00000682462.1 | c.4344G>A | p.Trp1448* | stop_gained | Exon 35 of 47 | ENSP00000507105.1 | ||||
CACNA1C | ENST00000683781.1 | c.4344G>A | p.Trp1448* | stop_gained | Exon 35 of 47 | ENSP00000507434.1 | ||||
CACNA1C | ENST00000683840.1 | c.4344G>A | p.Trp1448* | stop_gained | Exon 35 of 47 | ENSP00000507612.1 | ||||
CACNA1C | ENST00000683956.1 | c.4344G>A | p.Trp1448* | stop_gained | Exon 35 of 47 | ENSP00000506882.1 | ||||
CACNA1C | ENST00000399638.5 | c.4338G>A | p.Trp1446* | stop_gained | Exon 36 of 48 | 1 | ENSP00000382547.1 | |||
CACNA1C | ENST00000335762.10 | c.4329G>A | p.Trp1443* | stop_gained | Exon 36 of 48 | 5 | ENSP00000336982.5 | |||
CACNA1C | ENST00000399606.5 | c.4314G>A | p.Trp1438* | stop_gained | Exon 36 of 48 | 1 | ENSP00000382515.1 | |||
CACNA1C | ENST00000399621.5 | c.4254G>A | p.Trp1418* | stop_gained | Exon 35 of 47 | 1 | ENSP00000382530.1 | |||
CACNA1C | ENST00000399637.5 | c.4254G>A | p.Trp1418* | stop_gained | Exon 35 of 47 | 1 | ENSP00000382546.1 | |||
CACNA1C | ENST00000402845.7 | c.4254G>A | p.Trp1418* | stop_gained | Exon 35 of 47 | 1 | ENSP00000385724.3 | |||
CACNA1C | ENST00000399629.5 | c.4305G>A | p.Trp1435* | stop_gained | Exon 35 of 47 | 1 | ENSP00000382537.1 | |||
CACNA1C | ENST00000682336.1 | c.4296G>A | p.Trp1432* | stop_gained | Exon 35 of 47 | ENSP00000507898.1 | ||||
CACNA1C | ENST00000399591.5 | c.4221G>A | p.Trp1407* | stop_gained | Exon 34 of 46 | 1 | ENSP00000382500.1 | |||
CACNA1C | ENST00000399595.5 | c.4221G>A | p.Trp1407* | stop_gained | Exon 34 of 46 | 1 | ENSP00000382504.1 | |||
CACNA1C | ENST00000399649.5 | c.4215G>A | p.Trp1405* | stop_gained | Exon 34 of 46 | 1 | ENSP00000382557.1 | |||
CACNA1C | ENST00000399597.5 | c.4254G>A | p.Trp1418* | stop_gained | Exon 35 of 47 | 1 | ENSP00000382506.1 | |||
CACNA1C | ENST00000399601.5 | c.4254G>A | p.Trp1418* | stop_gained | Exon 35 of 47 | 1 | ENSP00000382510.1 | |||
CACNA1C | ENST00000399641.6 | c.4254G>A | p.Trp1418* | stop_gained | Exon 35 of 47 | 1 | ENSP00000382549.1 | |||
CACNA1C | ENST00000399644.5 | c.4254G>A | p.Trp1418* | stop_gained | Exon 35 of 47 | 1 | ENSP00000382552.1 | |||
CACNA1C | ENST00000682835.1 | c.4254G>A | p.Trp1418* | stop_gained | Exon 35 of 47 | ENSP00000507282.1 | ||||
CACNA1C | ENST00000683482.1 | c.4245G>A | p.Trp1415* | stop_gained | Exon 35 of 47 | ENSP00000507169.1 | ||||
CACNA1C | ENST00000682686.1 | c.4221G>A | p.Trp1407* | stop_gained | Exon 34 of 46 | ENSP00000507309.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Long QT syndrome Uncertain:1
Dec 16, 2016
Center For Human Genetics And Laboratory Diagnostics, Dr. Klein, Dr. Rost And Colleagues
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at